ConductScience.org, home

Paper40586556

Hydrophilic and Amphiphilic Macromolecules as Modulators of the Physical Stability and Bioavailability of Piribedil: A Study on Binary Mixtures and Micellar Systems.

Orszulak L and 14 others. Mol Pharm, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Hydrophilic and Amphiphilic Macromolecules as Modulators of the Physical Stability and Bioavailability of Piribedil: A Study on Binary Mixtures and Micellar Systems. Papers, record 40586556. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40586556

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hydrophilic and Amphiphilic Macromolecules as Modulators of the Physical Stability and Bioavailability of Piribedil: A Study on Binary Mixtures and Micellar Systems.
PubMed
Journal
Mol Pharm
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-08-08
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Orszulak LLuizahttps://orcid.org/0000-0002-7709-5867
2Minecka AAldonahttps://orcid.org/0000-0001-5603-032X
3Bernat RRoksana
4Lamrani TTaoufik
5Jurkiewicz KKarolinahttps://orcid.org/0000-0002-4289-7827
6Hachuła BBarbara
7Tarnacka MMagdalenahttps://orcid.org/0000-0002-9444-3114
8Geppert-Rybczyńska MMonikahttps://orcid.org/0000-0002-7112-9624
9Zubko MMaciej
10Staniszewska MMarcelahttps://orcid.org/0000-0002-6865-5471
11Smoleński MMichałhttps://orcid.org/0000-0002-6075-9866
12Dobosz JJustyna
13Garbacz GGrzegorz
14Kamiński KKamilhttps://orcid.org/0000-0002-5871-0203
15Kamińska EEwahttps://orcid.org/0000-0001-9725-8654

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PiribedilMajor topic
Biological Availability
Calorimetry, Differential Scanning
Chemistry, Pharmaceutical
Crystallization
Drug Compounding
Drug Liberation
Drug Stability
Hydrophobic and Hydrophilic Interactions
Micelles
Polyethylene Glycols
Polymers
Polyvinyls
Solubility
Spectroscopy, Fourier Transform Infrared
X-Ray Diffraction

Source PubMed

Download CSV of topics

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134273426Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson's disease.Int J Pharm2021https://conductscience.org/library/papers/34273426PubMed
237635801Advances in the development of amorphous solid dispersions: The role of polymeric carriers.Asian J Pharm Sci2023https://conductscience.org/library/papers/37635801PubMed
332905026Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition.J Drug Deliv Sci Technol2020https://conductscience.org/library/papers/32905026PubMed
432414187The Use of Poly(N-vinyl pyrrolidone) in the Delivery of Drugs: A Review.Polymers (Basel)2020https://conductscience.org/library/papers/32414187PubMed
534637312Zeta Potential and Colloidal Stability Predictions for Inorganic Nanoparticle Dispersions: Effects of Experimental Conditions and Electrokinetic Models on the Interpretation of Results.Langmuir2021https://conductscience.org/library/papers/34637312PubMed
631961694Influence of Annealing in the Close Vicinity of Tg on the Reorganization within Dimers and Its Impact on the Crystallization Kinetics of Gemfibrozil.Mol Pharm2020https://conductscience.org/library/papers/31961694PubMed
731704609Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): Optimisation and in-vitro characterisation.Colloids Surf B Biointerfaces2020https://conductscience.org/library/papers/31704609PubMed
822172603Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.Eur J Pharm Sci2012https://conductscience.org/library/papers/22172603PubMed
923383426Strategies to address low drug solubility in discovery and development.Pharmacol Rev2013https://conductscience.org/library/papers/23383426PubMed
1027267583The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.Expert Opin Drug Deliv2016https://conductscience.org/library/papers/27267583PubMed
1133277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
1215793805Calorimetric investigation of the structural relaxation of amorphous materials: evaluating validity of the methodologies.J Pharm Sci2005https://conductscience.org/library/papers/15793805PubMed
1330669484Micellisation Mechanism and Behaviour of Soluplus®⁻Furosemide Micelles: Preformulation Studies of an Oral Nanocarrier-Based System.Pharmaceuticals (Basel)2019https://conductscience.org/library/papers/30669484PubMed
1439608423Inhibition of naproxen crystallization by polymers: The role of topology and chain length of polyvinylpyrrolidone macromolecules.Eur J Pharm Biopharm2025https://conductscience.org/library/papers/39608423PubMed
1534952275Understanding the self-assembly of the polymeric drug solubilizer Soluplus®.J Colloid Interface Sci2022https://conductscience.org/library/papers/34952275PubMed
1635269593Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari-Goldstein Relaxations.Int J Mol Sci2022https://conductscience.org/library/papers/35269593PubMed
17240466902-{4-[(1,3-Benzodioxol-5-yl)meth-yl]piperazin-1-yl}pyrimidine.Acta Crystallogr Sect E Struct Rep Online2013https://conductscience.org/library/papers/24046690PubMed
1827344665Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.CNS Drugs2016https://conductscience.org/library/papers/27344665PubMed
1920600305From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease.Pharmacol Ther2010https://conductscience.org/library/papers/20600305PubMed
2023110256Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology.Drug Deliv Transl Res2012https://conductscience.org/library/papers/23110256PubMed

See all 71 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41477341ROS-scavenging nanomaterials as emerging tools for bone tissue regeneration: A comprehensive review of recent progress.Acta Pharm Sin B2025https://conductscience.org/library/papers/41477341

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40586556

GET https://conductscience.org/api/papers/v1/40586556/references?page=2